Drug Type Small molecule drug |
Synonyms ML291 |
Target- |
Action stimulants |
Mechanism Cell death stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | United States | 28 Feb 2013 | |
Diabetes Mellitus | Preclinical | United States | 28 Feb 2013 | |
Hemophilia | Preclinical | United States | 28 Feb 2013 | |
Lysosomal Storage Diseases | Preclinical | United States | 28 Feb 2013 | |
Neoplasms | Preclinical | United States | 28 Feb 2013 | |
Parkinson Disease | Preclinical | United States | 28 Feb 2013 |